Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc., a leading biopharmaceutical company based in the United States, focuses on developing innovative treatments for dermatological conditions. Founded in 2017, Arcutis has quickly established itself in the industry with a commitment to addressing unmet medical needs in skin health. The company’s core products include topical therapies designed to treat conditions such as psoriasis and atopic dermatitis, distinguished by their unique formulation and efficacy. Arcutis has achieved significant milestones, including successful clinical trials that have positioned it as a key player in the dermatology market. With a strong emphasis on research and development, Arcutis continues to advance its portfolio, aiming to improve the quality of life for patients suffering from skin disorders.
DitchCarbon Score
How does Arcutis Biotherapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Arcutis Biotherapeutics, Inc.'s score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Arcutis Biotherapeutics, Inc.'s reported carbon emissions
Arcutis Biotherapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Arcutis may not yet have established formal commitments to reduce its carbon footprint or engage in climate initiatives. As the biopharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Arcutis to consider setting measurable climate goals and participating in initiatives such as the Science Based Targets initiative (SBTi) to align with global climate efforts. Without specific emissions data or reduction commitments, Arcutis's position in the context of industry climate action remains unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Arcutis Biotherapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
